Stein Mart, Inc. Reports First Quarter Fiscal 2017 Results
May 17, 2017 20:07 pm UTC| Business
JACKSONVILLE, Fla., May 17, 2017 -- Stein Mart, Inc. (NASDAQ:SMRT) today announced financial results for the first quarter ended April 29, 2017. Highlights Total sales decreased 5.2 percent and comparable store sales...
Stein Mart, Inc. Reports First Quarter Fiscal 2017 Results
May 17, 2017 20:07 pm UTC| Business
JACKSONVILLE, Fla., May 17, 2017 -- Stein Mart, Inc. (NASDAQ:SMRT) today announced financial results for the first quarter ended April 29, 2017. Highlights Total sales decreased 5.2 percent and comparable store sales...
May 17, 2017 20:07 pm UTC| Business
MINNEAPOLIS, May 17, 2017 -- Tactile Systems Technology, Inc.(“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency, today...
May 17, 2017 20:07 pm UTC| Business
MINNEAPOLIS, May 17, 2017 -- Tactile Systems Technology, Inc.(“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency, today...
May 17, 2017 20:07 pm UTC| Business
MINNEAPOLIS, May 17, 2017 -- Tactile Systems Technology, Inc.(“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency, today...
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
May 17, 2017 20:06 pm UTC| Business
GERMANTOWN, Md., May 17, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it has completed dosing of the last subject...
Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder
May 17, 2017 20:06 pm UTC| Business
GERMANTOWN, Md., May 17, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it has completed dosing of the last subject...